Compare HCA Health Inc (HCA) vs Marathon Digital Holdings Inc (MARA) Price & Performance

HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.

The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.

MARA stock trades at $9.71, down 6.27% on the day, reflecting a volatile trend. The technical outlook is bearish overall, with moving averages signaling a downtrend, though oscillators suggest potential for a short-term bounce. Fundamentally, the company reported a net loss of $1.31 billion in 2025 with a negative net income margin of -429.71%, despite a high gross margin of 76.71%. Recent earnings have consistently missed expectations, with Q2 2026 EPS of -1.6 missing the expected 0.1666. Analyst sentiment is mixed, with a consensus price target of $13.25.

The outlook for MARA is challenged by persistent losses and negative profitability metrics, though low valuation ratios like a P/E of 3.37 may attract value investors. Key risks include execution challenges in achieving profitability, high cash burn from operations, and sensitivity to broader market sentiment. The stock's performance remains heavily influenced by news flow and sector momentum, requiring careful risk assessment for potential investors.